Global Anti-Snoring Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Treatment Type;
Device Types - Mandibular Advancement Devices (MAD), Tongue Stabilizing Devices (TSD), Continuous Positive Airway Pressure (CPAP) Devices and Other Device Types, Surgical Procedure - Uvulopalatopharyngoplasty (UPPP), Somnoplasty, Pillar Procedure, Tonsillectomy, Radiofrequency Palatoplasty, and Other Surgical Procedures.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Anti-Snoring Market (USD Million), 2021 - 2031
In the year 2024, the Global Anti-Snoring Market was valued at USD 1,734.07 million. The size of this market is expected to increase to USD 3,115.39 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.
The global anti-snoring market has witnessed significant growth in recent years, driven by increasing awareness of the health risks associated with snoring and sleep apnea. Snoring, often considered a minor inconvenience, can be indicative of more severe conditions such as obstructive sleep apnea (OSA), which can lead to serious cardiovascular issues if left untreated. This has spurred demand for various anti-snoring devices and solutions, ranging from simple nasal strips and mouthpieces to advanced continuous positive airway pressure (CPAP) machines. As the understanding of sleep health continues to evolve, so too does the market for anti-snoring products.
Technological advancements have played a crucial role in the expansion of the anti-snoring market. Innovative products such as smart pillows, wearable devices, and mobile apps that monitor and address snoring patterns have become increasingly popular. These solutions not only help in reducing snoring but also in providing valuable data to healthcare providers for better diagnosis and treatment. Additionally, the integration of artificial intelligence and machine learning in these devices has enhanced their effectiveness, making them more appealing to consumers seeking efficient and convenient ways to improve their sleep quality.
The market's growth is also fueled by demographic factors, particularly the aging global population and the rising prevalence of obesity, both of which are major risk factors for snoring and sleep apnea. As more people seek medical advice for sleep-related issues, the demand for effective anti-snoring treatments is expected to rise. Furthermore, increased consumer spending on health and wellness products, coupled with a growing emphasis on the importance of sleep, has propelled the market forward. With continuous research and development, the anti-snoring market is poised to offer even more advanced and accessible solutions in the coming years.
Global Anti-Snoring Market Recent Developments
-
In July 2022, Glidewell expanded its portfolio of mandibular advancement devices by launching the Silent Nite Sleep Appliance with Glidewell Hinge, designed to treat snoring and obstructive sleep apnea (OSA)
-
In June 2022, Illusion Aligners introduced a new oral Anti-Snoring Device (ASD), offering a comfortable, easy-to-wear, and effective solution for users
Segment Analysis
The global anti-snoring market is segmented into various categories based on product type, distribution channel, and region. Product types in this market include oral appliances, nasal devices, continuous positive airway pressure (CPAP) devices, chin straps, position control devices, and others. Among these, CPAP devices hold a significant market share due to their high efficacy in treating obstructive sleep apnea, a major cause of snoring. Oral appliances and nasal devices also contribute considerably to the market due to their ease of use and non-invasiveness. Position control devices and chin straps are gaining traction among users seeking non-invasive and comfortable solutions to manage snoring.
In terms of distribution channels, the market is segmented into hospitals, retail pharmacies, online stores, and others. Online stores have witnessed a significant surge in demand, attributed to the increasing preference for convenient and discreet purchasing options. Retail pharmacies continue to hold a substantial share as they provide accessibility and personalized advice from healthcare professionals. Hospitals also play a crucial role, particularly for patients requiring professional diagnosis and treatment of underlying conditions contributing to snoring, such as sleep apnea.
Geographically, the anti-snoring market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the market due to the high prevalence of sleep disorders, advanced healthcare infrastructure, and increased awareness about the health risks associated with snoring. Europe follows closely, with significant market growth driven by similar factors. The Asia Pacific region is expected to witness the fastest growth during the forecast period, fueled by a large population base, rising disposable incomes, and increasing awareness of sleep health. Latin America and the Middle East & Africa are also emerging markets with growing demand for anti-snoring devices, driven by improving healthcare infrastructure and rising awareness.
Global Anti-Snoring Segment Analysis
In this report, the global anti-snoring market has been segmented by treatment type and geography.
Global Anti-Snoring Market, Segmentation by Treatment Type
The Global Anti-Snoring Market has been segmented by Treatment Type into Device Types and Surgical Procedure.
The global anti-snoring market is segmented by treatment type into oral appliances, nasal devices, positional therapy, CPAP devices, and others. Oral appliances, including mandibular advancement devices (MADs) and tongue-retaining devices (TRDs), are among the most common treatments. They work by repositioning the jaw or tongue to maintain an open airway during sleep, making them a popular choice for individuals with mild to moderate snoring. These devices are favored due to their non-invasive nature and ease of use, offering a convenient solution for many snorers.
Nasal devices and positional therapy are also significant segments within the anti-snoring market. Nasal devices, such as nasal strips and dilators, help to widen the nasal passage, reducing airflow resistance and improving breathing. These devices are particularly beneficial for those whose snoring is exacerbated by nasal congestion. Positional therapy, on the other hand, involves the use of devices that encourage sleeping in positions less likely to induce snoring, such as side-sleeping. This method is often used in conjunction with other treatments to enhance overall effectiveness.
Continuous Positive Airway Pressure (CPAP) devices represent another critical segment in the market, especially for individuals with obstructive sleep apnea (OSA), a condition often associated with severe snoring. CPAP machines deliver a steady stream of air through a mask, keeping the airway open during sleep. While highly effective, CPAP devices are typically more suitable for severe cases due to their bulk and the need for a power source. Other treatments in the market include surgical options and lifestyle changes, which are often considered when non-invasive methods prove inadequate. The variety in treatment types highlights the diverse needs of individuals suffering from snoring, ensuring that there are tailored solutions available for different severity levels and underlying causes.
Global Anti-Snoring Market, Segmentation by Geography
In this report, the Global Anti-Snoring Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Anti-Snoring Market Share (%), by Geographical Region, 2024
The global anti-snoring market demonstrates significant regional variations in market share and growth potential, influenced by factors such as lifestyle, prevalence of sleep disorders, and technological advancements.
North America holds the largest share of the global anti-snoring market, driven by the high prevalence of sleep disorders and the presence of major market players. The region accounted for approximately 37.6% of the market share in 2022. This dominance is attributed to lifestyle factors such as high obesity rates and sedentary habits, which contribute to sleep apnea and snoring issues. Additionally, the U.S. has a significant number of individuals affected by snoring, with studies indicating that around 45% of adults snore occasionally, and 25% snore regularly.
Asia-Pacific (APAC) is experiencing the fastest growth rate in the anti-snoring market, with a projected compound annual growth rate (CAGR) of 8.3% during the forecast period. The market growth in this region is fueled by increasing awareness of sleep disorders, a growing aging population, and rising disposable incomes. Countries like China, Japan, and India are key contributors due to their large populations and increasing prevalence of obesity, which is closely linked to snoring and sleep apnea. Additionally, advancements in manufacturing capabilities and the introduction of innovative products are boosting market expansion in APAC .
Europe also plays a significant role in the anti-snoring market, driven by increasing healthcare awareness and the availability of advanced medical devices. European countries are focusing on improving sleep health, with a growing emphasis on diagnosing and treating sleep disorders. The presence of established market players and the rising adoption of innovative anti-snoring solutions contribute to the market's steady growth in this region. Countries like Germany, the UK, and France are leading in terms of market share due to their robust healthcare infrastructure and high awareness levels.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Anti-Snoring Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Awareness
- Technological Advancements
-
Growing Prevalence - The global anti-snoring market is experiencing significant growth due to several key factors. One major driver is the increasing prevalence of snoring and sleep-related breathing disorders, which is fueling demand for various anti-snoring devices and treatments. This growth is further propelled by the rising awareness of the health risks associated with untreated snoring and obstructive sleep apnea, such as cardiovascular issues and reduced quality of life (Market Data Forecast) (Mordor Intel).
Technological advancements in anti-snoring devices are also contributing to market expansion. Innovations such as nasal dilators, which offer a non-invasive and drug-free solution, and radiofrequency ablation (RFA), which provides a minimally invasive option with shorter recovery times, are gaining popularity. These devices cater to a growing consumer preference for effective yet comfortable and easy-to-use solutions.
Restraints:
- High Costs
- Low Compliance
-
Limited Effectiveness - The global anti-snoring market faces challenges in terms of effectiveness due to several factors. Firstly, the efficacy of various anti-snoring devices varies significantly among individuals. This means what works well for one person might not be as effective for another, necessitating a trial-and-error approach to finding the right solution. This variability is partly due to the differing underlying causes of snoring, such as nasal congestion, obesity, or sleep apnea (Delve Insight) (Mordor Intel).
Despite technological advancements and the development of various anti-snoring devices like CPAP machines, mandibular advancement devices (MADs), and nasal devices, the overall effectiveness and user satisfaction remain limited. Some users find these devices uncomfortable, and there can be a significant adjustment period, particularly with oral appliances. Additionally, custom-made devices, which are often more effective, come with high costs, posing affordability issues for many consumers.
Opportunities:
- Emerging Markets
- Product Innovations
-
Online Retail Expansion - The global anti-snoring market is witnessing significant growth, driven by an increasing awareness of the health impacts of snoring and sleep apnea. Technological advancements in anti-snoring devices and treatments, such as continuous positive airway pressure (CPAP) machines, nasal strips, and smart pillows, have broadened the range of available solutions, catering to diverse consumer needs. The rising prevalence of obesity and related health issues, which contribute to snoring, has further propelled demand. Additionally, a growing aging population, which is more susceptible to sleep disorders, is contributing to the expansion of this market.
Online retail has played a crucial role in the expansion of the anti-snoring market, offering consumers easy access to a wide variety of products. E-commerce platforms like Amazon, eBay, and specialized health stores have enabled manufacturers to reach a global audience, eliminating geographical limitations. The convenience of home delivery, coupled with the availability of customer reviews and competitive pricing, has made online shopping an attractive option for consumers. Furthermore, the integration of artificial intelligence and machine learning in online retail has enhanced personalized marketing, helping customers find products best suited to their specific needs and preferences.
Competitive Landscape Analysis
Key players in Global Anti-Snoring Market include:
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips NV
- Resmed
- ASF Medical GmbH (Tomed GmbH)
- Apnea Sciences
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Region
- Global Anti-Snoring Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Awareness
- Technological Advancements
- Growing Prevalence
- Restraints
- High Costs
- Low Compliance
- Limited Effectiveness
- Opportunities
- Emerging Markets
- Product Innovations
- Online Retail Expansion
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Compititive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Anti-Snoring Market, By Treatment Type, 2021 - 2031 (USD Million)
- Device Types
- Mandibular Advancement Devices (MAD)
- Tongue Stabilizing Devices (TSD)
- Continuous Positive Airway Pressure (CPAP) Devices
- Other Device Types
- Surgical Procedure
- Uvulopalatopharyngoplasty (UPPP)
- Somnoplasty
- Pillar Procedure
- Tonsillectomy
- Radiofrequency Palatoplasty
- Other Surgical Procedures
- Device Types
- Global Anti-Snoring Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Anti-Snoring Market, By Treatment Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips NV
- Resmed
- ASF Medical GmbH (Tomed GmbH)
- Apnea Sciences
- Company Profiles
- Analyst Views
- Future Outlook of the Market